89 related articles for article (PubMed ID: 15275632)
1. Peroxisome proliferator-activated receptor gamma; Its role in atherosclerosis and restenosis.
Pakala R; Rha SW; Kuchulakanti PK; Cheneau E; Baffour R; Waksman R
Cardiovasc Radiat Med; 2004; 5(1):44-8. PubMed ID: 15275632
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ribonucleotide reductase reduces neointimal formation following balloon injury.
Henry JC; Bonar MM; Kearns PN; Cui H; Mutchler MM; Martin MV; Orsini AR; Elford HL; Bush CA; Zweier JL; Cardounel AJ
J Pharmacol Exp Ther; 2005 Jul; 314(1):70-6. PubMed ID: 15814568
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor alpha and gamma ligands differentially affect smooth muscle cell proliferation and migration.
Zahradka P; Wright B; Fuerst M; Yurkova N; Molnar K; Taylor CG
J Pharmacol Exp Ther; 2006 May; 317(2):651-9. PubMed ID: 16407462
[TBL] [Abstract][Full Text] [Related]
4. Effects of combined treatment with angiotensin II type 1 receptor blocker and statin on stent restenosis.
Yoshikawa M; Nakamura K; Nagase S; Sakuragi S; Kusano KF; Matsubara H; Ohe T
J Cardiovasc Pharmacol; 2009 Feb; 53(2):179-86. PubMed ID: 19188828
[TBL] [Abstract][Full Text] [Related]
5. Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform.
Jaschke B; Michaelis C; Milz S; Vogeser M; Mund T; Hengst L; Kastrati A; Schömig A; Wessely R
Cardiovasc Res; 2005 Dec; 68(3):483-92. PubMed ID: 16111664
[TBL] [Abstract][Full Text] [Related]
6. Emodin induces growth arrest and death of human vascular smooth muscle cells through reactive oxygen species and p53.
Wang X; Zou Y; Sun A; Xu D; Niu Y; Wang S; Wang K; Ge J
J Cardiovasc Pharmacol; 2007 May; 49(5):253-60. PubMed ID: 17513942
[TBL] [Abstract][Full Text] [Related]
7. Comparative characterization of cellular and molecular anti-restenotic profiles of paclitaxel and sirolimus. Implications for local drug delivery.
Wessely R; Blaich B; Belaiba RS; Merl S; Görlach A; Kastrati A; Schömig A
Thromb Haemost; 2007 Jun; 97(6):1003-12. PubMed ID: 17549304
[TBL] [Abstract][Full Text] [Related]
8. Vitamin A: a drug for prevention of restenosis/reocclusion after percutaneous coronary intervention?
Gidlöf AC; Ocaya P; Krivospitskaya O; Sirsjö A
Clin Sci (Lond); 2008 Jan; 114(1):19-25. PubMed ID: 18047466
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo.
Hacker TA; Griffin MO; Guttormsen B; Stoker S; Wolff MR
J Invasive Cardiol; 2007 Jun; 19(6):269-74. PubMed ID: 17541129
[TBL] [Abstract][Full Text] [Related]
10. Probucol mediates vascular remodeling after percutaneous transluminal angioplasty via down-regulation of the ERK1/2 signaling pathway.
Yang YB; Yang YX; Su B; Tang YL; Zhu BY; Hu ZW; Li GY; Li YJ; Liao DF
Eur J Pharmacol; 2007 Sep; 570(1-3):125-34. PubMed ID: 17628533
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of peroxisome proliferator-activated receptor-gamma and NADPH oxidases are involved in restenosis after balloon injury.
Qin HD; Huang D; Weng XD; Xu F
J Cell Physiol; 2009 Nov; 221(2):387-93. PubMed ID: 19562688
[TBL] [Abstract][Full Text] [Related]
12. Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists.
Libby P; Plutzky J
Am J Cardiol; 2007 Feb; 99(4A):27B-40B. PubMed ID: 17307056
[TBL] [Abstract][Full Text] [Related]
13. Angio-associated migratory cell protein and smooth muscle cell migration in development of restenosis and atherosclerosis.
Holvoet P; Sinnaeve P
J Am Coll Cardiol; 2008 Jul; 52(4):312-4. PubMed ID: 18634988
[No Abstract] [Full Text] [Related]
14. Molecular signatures determining coronary artery and saphenous vein smooth muscle cell phenotypes: distinct responses to stimuli.
Deng DX; Spin JM; Tsalenko A; Vailaya A; Ben-Dor A; Yakhini Z; Tsao P; Bruhn L; Quertermous T
Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1058-65. PubMed ID: 16456091
[TBL] [Abstract][Full Text] [Related]
15. Oxidized lipid-driven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferator-activated receptor gamma-dependent pathway.
Barlic J; Zhang Y; Foley JF; Murphy PM
Circulation; 2006 Aug; 114(8):807-19. PubMed ID: 16908772
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human pulmonary artery smooth muscle cell proliferation and migration by sabiporide, a new specific NHE-1 inhibitor.
Wu D; Doods H; Stassen JM
J Cardiovasc Pharmacol; 2006 Aug; 48(2):34-40. PubMed ID: 16954819
[TBL] [Abstract][Full Text] [Related]
17. Antioxidants relieve phosphatase inhibition and reduce PDGF signaling in cultured VSMCs and in restenosis.
Kappert K; Sparwel J; Sandin A; Seiler A; Siebolts U; Leppänen O; Rosenkranz S; Ostman A
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2644-51. PubMed ID: 16990553
[TBL] [Abstract][Full Text] [Related]
18. [Expression of peroxisome proliferator-activated receptors Y changes with age in vascular smooth muscle cells of spontaneously hypertensive rat].
Di ZL; Niu XL; Wei J; Li YQ; Chen GL; Wang NP
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):204-7. PubMed ID: 16608075
[TBL] [Abstract][Full Text] [Related]
19. Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology.
Wray J; Bishop-Bailey D
Exp Physiol; 2008 Jan; 93(1):148-54. PubMed ID: 17872966
[TBL] [Abstract][Full Text] [Related]
20. Human urotensin II as a link between hypertension and coronary artery disease.
Watanabe T; Kanome T; Miyazaki A; Katagiri T
Hypertens Res; 2006 Jun; 29(6):375-87. PubMed ID: 16940699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
